ellipticine has been researched along with Central Nervous System Neoplasm in 2 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devraj, R | 1 |
| Barrett, JF | 1 |
| Fernandez, JA | 1 |
| Katzenellenbogen, JA | 1 |
| Cushman, M | 1 |
| Anderson, WK | 1 |
| Gopalsamy, A | 1 |
| Reddy, PS | 1 |
2 other studies available for ellipticine and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Survival; Central Nerv | 1996 |
Design, synthesis, and study of 9-substituted ellipticine and 2-methylellipticinium analogues as potential CNS-selective antitumor agents.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Drug Design; Drug Screening Assays, Antitum | 1994 |